Identifying the targets of the amplifying pathway for insulin secretion in pancreatic beta-cells by kinetic modeling of granule exocytosis
- PMID: 18515381
- PMCID: PMC2517041
- DOI: 10.1529/biophysj.107.124990
Identifying the targets of the amplifying pathway for insulin secretion in pancreatic beta-cells by kinetic modeling of granule exocytosis
Abstract
A kinetic model for insulin secretion in pancreatic beta-cells is adapted from a model for fast exocytosis in chromaffin cells. The fusion of primed granules with the plasma membrane is assumed to occur only in the "microdomain" near voltage-sensitive L-type Ca(2+)-channels, where [Ca(2+)] can reach micromolar levels. In contrast, resupply and priming of granules are assumed to depend on the cytosolic [Ca(2+)]. Adding a two-compartment model to handle the temporal distribution of Ca(2+) between the microdomain and the cytosol, we obtain a unified model that can generate both the fast granule fusion and the slow insulin secretion found experimentally in response to a step of membrane potential. The model can simulate the potentiation induced in islets by preincubation with glucose and the reduction in second-phase insulin secretion induced by blocking R-type Ca(2+)-channels (Ca(V)2.3). The model indicates that increased second-phase insulin secretion induced by the amplifying signal is controlled by the "resupply" step of the exocytosis cascade. In contrast, enhancement of priming is a good candidate for amplification of first-phase secretion by glucose, cyclic adenosine 3':5'-cyclic monophosphate, and protein kinase C. Finally, insulin secretion is enhanced when the amplifying signal oscillates in phase with the triggering Ca(2+)-signal.
Figures
References
-
- Eddlestone, G. T., A. Goncalves, J. A. Bangham, and E. Rojas. 1984. Electrical coupling between cells in islets of Langerhans from mouse. J. Membr. Biol. 77:1–14. - PubMed
-
- Jonkers, F. C., and J. C. Henquin. 2001. Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits β-cells and gradually increases the individual cell response. Diabetes. 50:540–550. - PubMed
-
- Brenner, M. B., J. Gromada, A. M. Efanov, K. Bokvist, and H. J. Mest. 2003. Restoration of first-phase insulin secretion by the imidazoline compound LY374284 in pancreatic islets of diabetic db/db mice. Ann. N. Y. Acad. Sci. 1009:332–340. - PubMed
-
- Gerich, J. E. 2002. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes. 51(Suppl. 1):S117–S121. - PubMed
-
- Chow, R. H., L. von Ruden, and E. Neher. 1992. Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells. Nature. 356:60–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
